Increasing the diagnostic yield of renal angiography for the diagnosis of atheromatous renovascular disease

The British Journal of Radiology
A E ShurrabP A Kalra

Abstract

Atheromatous renovascular disease (ARVD) is a common cause of hypertension and chronic renal failure (CRF). In this unit, intravenous digital subtraction angiography (DSA) (or intraarterial DSA if indicated) is used as a screening angiographic study when ARVD is suspected. However, increased use of these investigations has resulted in a longer waiting time for angiography. As the majority of studies are negative for ARVD, clinical features and results of investigations of patients undergoing angiography were reviewed to identify those having the greatest likelihood of ARVD. The clinical notes were reviewed for all 249 patients undergoing angiography over an 18-month period. Primary indications for investigation were: hypertension 71 (28.5%), CRF 156 (62.7%) and CRF with severe hypertension 22 (8.8%). 12 of the CRF patients had end-stage renal failure. 166 (66.7%) patients had no evidence of ARVD, while only 83 (33.3%) patients showed some degree of ARVD, 29 (35%) of which had bilateral renal artery disease. There was no significant difference between the ARVD group and the non-ARVD group for mean age (69.0 years vs 63.3 years), male to female ratio, history of smoking (68.7% vs 55.4%), severe hypertension (10.8% vs 9.0%), hyper...Continue Reading

References

Jan 1, 1991·The American Journal of Medicine·S J MannJ H Laragh
Nov 24, 1990·BMJ : British Medical Journal·A H ChoudhriM A al-Kutoubi
Jul 1, 1990·Southern Medical Journal·L P SvetkeyP E Klotman
Mar 1, 1988·The British Journal of Radiology·R RobertsonP A Dubbins
Apr 1, 1986·The American Journal of Medicine·F B MullerJ H Laragh
Oct 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·L U MaillouxR T Mossey
Aug 1, 1994·American Journal of Surgery·S M HertzJ P Carpenter
May 1, 1993·Annals of Internal Medicine·J M Rimmer, F J Gennari
Nov 1, 1996·American Journal of Hypertension·R E ZierlerD E Strandness
Aug 1, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J RiehlH G Sieberth
Jan 23, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·V E GhantousF O Finkelstein
Mar 31, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·P J ConlonP A Kalra

❮ Previous
Next ❯

Citations

Jul 7, 2010·Journal of the Chinese Medical Association : JCMA·Yee-Yung NgShiao-Chi Wu
Nov 18, 2009·Progress in Cardiovascular Diseases·Constantina Chrysochou, Philip A Kalra
Feb 27, 2003·Internal Medicine Journal·S PrasadJ Taylor
Jun 30, 2005·Journal of Cardiac Surgery·Vedat ErentugCevat Yakut
Jun 22, 2012·Annals of Medicine·James RitchiePhilip A Kalra
Aug 8, 2006·The Journal of Urology·Bettina JørgensenMichael Pedersen
Nov 8, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·A J Nicholls
Jun 1, 2002·Journal of the American Society of Nephrology : JASN·Stephan R Orth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

© 2021 Meta ULC. All rights reserved